PT  - JOURNAL ARTICLE
AU  - Omori, Ryosuke
AU  - Matsuyama, Ryota
AU  - Nakata, Yukihiko
TI  - Does susceptibility to novel coronavirus (COVID-19) infection differ by age?: Insights from mathematical modelling
AID  - 10.1101/2020.06.08.20126003
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.08.20126003
4099  - http://medrxiv.org/content/early/2020/06/09/2020.06.08.20126003.short
4100  - http://medrxiv.org/content/early/2020/06/09/2020.06.08.20126003.full
AB  - Among Italy, Spain, and Japan, the age distributions of novel coronavirus (COVID-19) mortality show only small variation even though the number of deaths per country shows large variation. To understand the determinant for this situation, we constructed a mathematical model describing the transmission dynamics and natural history of COVID-19 and analyzed the dataset of fatal cases of COVID-19 in Italy, Spain, and Japan. We estimated the parameter which describes the age-dependency of susceptibility by fitting the model to reported data, taking into account the effect of change in contact patterns during the outbreak of COVID-19, and the fraction of symptomatic COVID-19 infections. Our modelling study revealed that if the mortality rate or the fraction of symptomatic infections among all COVID-19 cases does not depend on age, then unrealistically different age-dependencies of susceptibilities against COVID-19 infections between Italy, Japan, and Spain are required to explain the similar age distribution of mortality but different basic reproduction numbers (R0). Variation of susceptibility by age itself cannot explain the robust age distribution in mortality by COVID-19 in those three countries, however it does suggest that the age-dependencies of i) the mortality rate and ii) the fraction of symptomatic infections among all COVID-19 cases determine the age distribution of mortality by COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementR.O. acknowledges support from the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists 19K20393. Y.N. was supported by JSPS Grant-in-Aid for Young Scientists (B) 16K20976.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and Supporting Information files.